How do you integrate dd-cfDNA into the evaluation and management of ACR in lung transplant recipients?

We have been using dd-cfDNA in the context of a clinical investigation during the first-year post-transplant. We haven't yet used it outside this context but we are planning to after our institution sets up a payment mechanism to do so. We have been obtaining dd-cfDNA at 3 mo intervals during the fi...